| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 119.593 | 118.994 | 402.998 | 343.858 |
| Total Income - EUR | - | - | - | - | - | - | 119.594 | 122.046 | 403.066 | 344.638 |
| Total Expenses - EUR | - | - | - | - | - | - | 89.721 | 103.204 | 286.497 | 246.569 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 29.874 | 18.842 | 116.568 | 98.069 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 28.919 | 17.940 | 113.143 | 88.913 |
| Employees | - | - | - | - | - | - | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Its Bio-Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 390 | 27.578 | 19.938 | 14.010 |
| Current Assets | - | - | - | - | - | - | 70.171 | 34.849 | 305.085 | 100.872 |
| Inventories | - | - | - | - | - | - | 0 | 4.957 | 6.903 | 44.516 |
| Receivables | - | - | - | - | - | - | 26.237 | 6.843 | 287.014 | 10.999 |
| Cash | - | - | - | - | - | - | 43.934 | 23.049 | 11.168 | 45.357 |
| Shareholders Funds | - | - | - | - | - | - | 29.121 | 40.748 | 147.175 | 89.154 |
| Social Capital | - | - | - | - | - | - | 202 | 203 | 202 | 201 |
| Debts | - | - | - | - | - | - | 41.440 | 21.679 | 177.849 | 25.840 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Its Bio-Med S.r.l.